Abstract:Background: Radiation nanomedicines are nanoparticles labeled with radionuclides that emit α- or β-particles or Auger electrons for cancer treatment. We describe here our 15 years scientific journey studying locally-administered radiation nanomedicines for cancer treatment. We further present a view of the radiation nanomedicine landscape by reviewing research reported by other groups. Main body: Gold nanoparticles were studied initially for radiosensitization of breast cancer to X-radiation therapy. These nanoparticles were labeled with 111In to assess their biodistribution after intratumoural vs. intravenous injection. Intravenous injection was limited by high liver and spleen uptake and low tumour uptake, while intratumoural injection provided high tumour uptake but low normal tissue uptake. Further, [111In]In-labeled gold nanoparticles modified with trastuzumab and injected iintratumourally exhibited strong tumour growth inhibition in mice with subcutaneous HER2-positive human breast cancer xenografts. In subsequent studies, strong tumour growth inhibition in mice was achieved without normal tissue toxicity in mice with human breast cancer xenografts injected intratumourally with gold nanoparticles labeled with β-particle emitting 177Lu and modified with panitumumab or trastuzumab to specifically bind EGFR or HER2, respectively. A nanoparticle depot (nanodepot) was designed to incorporate and deliver radiolabeled gold nanoparticles to tumours using brachytherapy needle insertion techniques. Treatment of mice with s.c. 4T1 murine mammary carcinoma tumours with a nanodepot incorporating [90Y]Y-labeled gold nanoparticles inserted into one tumour arrested tumour growth and caused an abscopal growth-inhibitory effect on a distant second tumour. Convection-enhanced delivery of [177Lu]Lu-AuNPs to orthotopic human glioblastoma multiforme (GBM) tumours in mice arrested tumour growth without normal tissue toxicity. Other groups have explored radiation nanomedicines for cancer treatment in preclinical animal tumour xenograft models using gold nanoparticles, liposomes, block copolymer micelles, dendrimers, carbon nanotubes, cellulose nanocrystals or iron oxide nanoparticles. These nanoparticles were labeled with radionuclides emitting Auger electrons (111In, 99mTc, 125I, 103Pd, 193mPt, 195mPt), β-particles (177Lu, 186Re, 188Re, 90Y, 198Au, 131I) or α-particles (225Ac, 213Bi, 212Pb, 211At, 223Ra). These studies employed intravenous or intratumoural injection or convection enhanced delivery. Local administration of these radiation nanomedicines was most effective and minimized normal tissue toxicity. Conclusions: Radiation nanomedicines have shown great promise for treating cancer in preclinical studies. Local intratumoural administration avoids sequestration by the liver and spleen and is most effective for treating tumours, while minimizing normal tissue toxicity.

Nano-radiopharmaceuticals as therapeutic agents

Nanoparticle-based theranostics in nuclear medicine

Nanoscale Radiotheranostics for Cancer Treatment: From Bench to Bedside

Radio-nanomaterials for Biomedical Applications: State of the Art.

Application of Nanomaterials in Biomedical Imaging and Cancer Therapy

Nanotechnology based therapeutic application in cancer diagnosis and therapy

Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy

Recent nanotheranostic approaches in cancer research

Application of Technetium 99 Metastable Radioactive Nanosystems: Nanoparticles, Liposomes, and Nanoemulsion for Biomedical Application

Nanooncology: The future of cancer diagnosis and therapy

Therapeutic Applications of Nanomedicine: Recent Developments and Future Perspectives

Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation

Synthetic nanoparticles for delivery of radioisotopes and radiosensitizers in cancer therapy

Delivery of therapeutic radioisotopes using nanoparticle platforms: potential benefit in systemic radiation therapy.

The Role of Nanomaterials in Diagnosis and Targeted Drug Delivery

Molecular Imaging and Therapy of Cancer with Radiolabeled Nanoparticles.

Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer

Chemoradiotherapy and nanomedicine: Drug mechanisms and delivery systems

An updated landscape on nanotechnology-based drug delivery, immunotherapy, vaccinations, imaging, and biomarker detections for cancers: recent trends and future directions with clinical success

Radiation nanomedicines for cancer treatment: a scientific journey and view of the landscape

Theranostic nanoparticles with disease-specific administration strategies